Awards & Advancement

Omeros adds two new vice presidents to management team

Friday, October 19, 2012 02:21 PM

Omeros, a Seattle, Wash.-based clinical-stage biopharmaceutical company targeting inflammation, coagulopathies and disorders of the central nervous system, has appointed two new vice presidents: Cathy Melfi, Ph.D. as vice president, regulatory affairs and quality systems, and Albert Yu, M.D., as vice president, clinical development.

More... »

Cytos Biotechnology appoints Itin as CEO

Friday, October 12, 2012 02:29 PM

Cytos Biotechnology, a Swiss biotech company focused on the development of CYT003 in allergic asthma, has appointed Dr. Christian Itin as chief executive officer. The board of directors will propose to the company's shareholders that Itin be elected as member of the board, and it is intended that he will become chairman.

More... »

Hantash joins PharmaNet/i3

Friday, October 12, 2012 02:06 PM

PharmaNet/i3, inVentiv Health’s clinical segment and a provider of clinical development services, has appointed Jamil Hantash, MSc, M.B.A., as director of Immunochemistry Operations at PharmaNet/i3’s Princeton, N.J., bioanalytical laboratory. 

More... »

PTC Therapeutics appoints Zeldis to board of directors

Thursday, October 4, 2012 12:14 PM

PTC Therapeutics, a biopharmaceutical company based in South Plainfield, N.J., has appointed Jerome B. Zeldis, M.D., Ph.D., to the company's board of directors.

More... »

Hagop Kantarjian joins Actinium Pharmaceuticals’ clinical advisory board

Wednesday, October 3, 2012 09:39 AM

Actinium Pharmaceuticals (API), a New York-based biopharmaceutical company focused on immunotherapeutics, has appointed Hagop Kantarjian, MD, to the company's clinical advisory board. 

More... »

Third Rock Ventures names entrepreneur-in-residence

Tuesday, October 2, 2012 01:57 PM

Boston-based Third Rock Ventures, a venture capital firm focused on building life sciences companies, has named Felix W. Frueh, Ph.D., an entrepreneur-in-residence (EIR). As an EIR, Dr. Frueh will provide strategic input on new and existing portfolio companies with a particular focus on personalized medicine.

More... »

SIRO Clinpharm named Indian CRO of the Year 2012

Monday, October 1, 2012 09:20 AM

SIRO Clinpharm, a drug development solutions provider, has been awarded the 'Indian CRO of the Year 2012' by Frost & Sullivan, a global growth partnership and consulting firm.

More... »

CRI Lifetree appoints Craig-Rodriguez and Marcos to leadership team

Friday, September 28, 2012 02:59 PM

CRI Lifetree, a multi-therapeutic early stage research company, has strengthened its early phase leadership with the appointments of Alicia Craig-Rodriguez as chief operating officer and Jose Marcos as East Coast director of clinical operations. 

More... »

ICON adds two to leadership teams in Asia Pacific and Latin America

Friday, September 28, 2012 02:47 PM

ICON,a global provider of outsourced development services, has appointed new members to its Asia Pacific & Latin American teams. New members include Wei Ming Goh as vice president of Asia Pacific and Dennis Hurley as vice president of Latin America.

More... »

NW Bio appoints vet Rosskamp as CEO of German subsidiary

Friday, September 21, 2012 01:24 PM

Northwest Biotherapeutics, a biotech developing DCVaxR personalized immune therapies for cancer, has appointed former pharmaceutical industry executive Dr. Gunter Rosskamp as the CEO of the company's German subsidiary, Northwest Biotherapeutics, Gmbh.

More... »